ASX:IMMPharmaceuticals, Biotechnology & Life SciencesBiotechnology
IMMUTEP ORD
$0.060
+$0.004 (+7.14%)
Day Range
$0.055 - $0.065
52 Week Range
$0.028 - $0.470
Volume
35.20M
Avg Volume (10D)
17.22M
Market Cap
$88.42M
Price Chart
Market Statistics
Open$0.055
Previous Close$0.056
Day High$0.065
Day Low$0.055
52 Week High$0.470
52 Week Low$0.028
Valuation
Market Cap88.42M
Shares Outstanding1.47B
Price to Book0.88
Trading Activity
Volume35.20M
Value Traded2.17M
Bid$0.060 × 3,254,850
Ask$0.062 × 600,000
Performance
1 Day0.00%
5 Day0.00%
13 Week-84.87%
52 Week-79.66%
YTD-85.78%
Technical Indicators
RSI (14)38.58
50-Day SMA$0.095
200-Day SMA$0.260
Latest News
Hot Topics
Weekly Wrap: Shares fall another 2.6% for the week as conflict worsens
ASX 200 slides 2.6% this week to 8,617 as Iran-Israel conflict lifts oil above $100; NST and SYR plunge, while EOS soars on a Middle East contract.
3 min read
Biotechnology
Immutep doses first patient in Phase II/III efti trial to treat metastatic breast cancer
Biotechnology company Immutep (ASX: IMM) has safely dosed the first patient at a European clinical site for its integrated Phase II/III AIPAC-003 trial to treat metastatic breast cancer. AIPAC-003 is evaluating the company’s soluble LAG-3 protein and first-in-class MHC Class II agonist known as eftilagimod alpha (efti) in combination with standard-of-care paclitaxel for the treatment […]
2 min read
